Oxford

Health | Comment 11 September 2020 By Clare Wilson Michelle D’Urbano The has been great alarm over the news that a trial of a vaccine candidate for the coronavirus, from the University of Oxford and drug firm AstraZeneca, has had to be put on hold after a participant developed strange neurological symptoms. It might seem…

By Michael Le Page One of the first volunteers takes part in the South African Oxford vaccine trialSIPHIWE SIBEKO/POOL/AFP via Getty Images An experimental coronavirus vaccine developed at the University of Oxford produces the hoped for immune responses in people. Even though it isn’t yet clear if this means the vaccine will prevent infections, the…

Share on PinterestWill the Oxford vaccine turn the tide of the pandemic?Image credit: Steve Parsons / POOL / AFPAmong the myriad of vaccine candidates that researchers across the globe are developing to stop the spread of the new coronavirus, SARS-CoV-2, the Oxford vaccine has already garnered significant attention.The vaccine, which the researchers call ChAdOx1 nCoV-19…

A senior British official has called the latest news on an Oxford University team's potential coronavirus vaccine "extremely encouraging." The results of the Phase I/II trial of the vaccine being developed by Oxford's Jenner Institute, in conjunction with pharmaceutical giant AstraZeneca, showed that it is safe and "produced strong immune results," according to the research…

COVID-19 vaccine trial shows promising results COVID-19 vaccine trial shows promising result... 03:29 A senior British official has called the latest news on an Oxford University team's potential coronavirus vaccine "extremely encouraging." The results of the Phase I/II trial of the vaccine being developed by Oxford's Jenner Institute, in conjunction with pharmaceutical giant AstraZeneca, showed…